Abstract：
BACKGROUND: Familial hypercholesterolaemia (FH) is a genetic condition that is a preventable cause of premature cardiovascular morbidity and mortality. High-level evidence and clinical practice guidelines support preventative care for people with FH. However, it is estimated that less than 10% of people at risk of FH have been detected using any approach across Australian health settings. The aim of this study was to identify the implementation barriers to and facilitators of the detection of FH in Australia.
METHODS: Four, 2-hour virtual focus groups were facilitated by implementation scientists and a clinicians as part of the 2021 Australasian FH Summit. Template analysis was used to identify themes.
RESULTS: There were 28 workshop attendees across four groups (n=6-8 each), yielding 13 barriers and 10 facilitators across three themes: (1) patient related, (2) provider related, and (3) system related. A \"lack of care pathways\" and \"upskilling clinicians in identifying and diagnosing FH\" were the most interconnected barriers and facilitators for the detection of FH.
CONCLUSIONS: The relationships between barriers and facilitators across the patient, provider, and system themes indicates that a comprehensive implementation strategy is needed to address these different levels. Future research is underway to develop a model for implementing the Australian FH guidelines into practice.
METHODS: Four, 2-hour virtual focus groups were facilitated by implementation scientists and a clinicians as part of the 2021 Australasian FH Summit. Template analysis was used to identify themes.
RESULTS: There were 28 workshop attendees across four groups (n=6-8 each), yielding 13 barriers and 10 facilitators across three themes: (1) patient related, (2) provider related, and (3) system related. A \"lack of care pathways\" and \"upskilling clinicians in identifying and diagnosing FH\" were the most interconnected barriers and facilitators for the detection of FH.
CONCLUSIONS: The relationships between barriers and facilitators across the patient, provider, and system themes indicates that a comprehensive implementation strategy is needed to address these different levels. Future research is underway to develop a model for implementing the Australian FH guidelines into practice.
摘要：
背景：家族性高胆固醇血症（FH）是一种遗传性疾病，是心血管疾病过早发病和死亡的可预防原因。高级证据和临床实践指南支持FH患者的预防性护理。然而,据估计,在澳大利亚的健康环境中,使用任何方法检测到的FH风险人群不到10%.这项研究的目的是确定在澳大利亚发现FH的实施障碍和促进因素。
方法：四，作为2021年澳大利亚FH峰会的一部分，实施科学家和临床医生为2小时的虚拟焦点小组提供了便利。模板分析用于确定主题。
结果：四组共28名研讨会参与者（每组n=6-8），在三个主题中产生13个障碍和10个促进者：(1)患者相关，(2)提供者相关，(3)系统相关。“缺乏护理途径”和“提高临床医生识别和诊断FH的技能”是检测FH的最相互关联的障碍和促进因素。
结论：患者的障碍和促进者之间的关系，提供者,和系统主题表明，需要一个全面的实施战略来解决这些不同的层面。未来的研究正在进行中，以开发一种将澳大利亚FH指南付诸实践的模型。
方法：四，作为2021年澳大利亚FH峰会的一部分，实施科学家和临床医生为2小时的虚拟焦点小组提供了便利。模板分析用于确定主题。
结果：四组共28名研讨会参与者（每组n=6-8），在三个主题中产生13个障碍和10个促进者：(1)患者相关，(2)提供者相关，(3)系统相关。“缺乏护理途径”和“提高临床医生识别和诊断FH的技能”是检测FH的最相互关联的障碍和促进因素。
结论：患者的障碍和促进者之间的关系，提供者,和系统主题表明，需要一个全面的实施战略来解决这些不同的层面。未来的研究正在进行中，以开发一种将澳大利亚FH指南付诸实践的模型。
